Topics

Alzamend Neuro, Inc. Company Profile

21:17 EDT 19th July 2019 | BioPortfolio

Alzamend Neuro™, Inc. is a Delaware corporation with its corporate headquarters in the State of Florida. The mission of Alzamend Neuro™ is to support the full product development life cycle of treatment and cures for Alzheimer’s driven by the belief that strong support of research is the foundation for true innovation. The Company is providing current hope through the commercialization of existing patented intellectual property and know-how while simultaneously funding future hope through advanced research and development. Alzamend Neuro’s™ underlying goal is to get a treatment or cure for Alzheimer’s to market at a reasonable cost as quickly as possible. Far too many suffer daily, patients and caretakers alike, from the burden created by the nation’s 6th leading cause of death and ‘most feared disease.’


News Articles [69 Associated News Articles listed on BioPortfolio]

Alzamend Neuro™ Completes New Management Team for 2019

Tampa, Fla., Dec. 26, 2018 (GLOBE NEWSWIRE) -- Alzamend Neuro™, Inc. (Alzamend™ or the “Company”) announced today that it has appointed top-tier financial executive, Kenneth S. Cragun, CPA,...

FDA expands indication for Insightec’s Exablate Neuro for PD

Insightec said the Exablate Neuro is a focused ultrasound device for performing incisionless thalamotomy guided by MR imaging. The expansion adds medication-refractory tremor from PD to the current T...

MRI Interventions Receives FDA Clearance for ClearPoint PURSUIT Neuro Aspiration System

MRI Interventions (OTCQB:MRIC), a platform neurosurgery company with products designed for navigation in procedures involving deep-brain stimulation, ablation, and gene and drug delivery today announc...

Alzamend Neuro™ Announces First Appointment to Scientific Advisory Board

Appoints Dr. Thomas Wisniewski, Leading Pioneer in Alzheimer’s Disease Alzamend Neuro™, Inc. (Alzamend™ or the “Company”) announced today that it had appointed its first member to its Scie...

Alzamend Neuro™ Announces Senior Management to Participate in the 2019 Alzheimer’s Association International Conference®

Alzamend Neuro™, Inc. (Alzamend™ or the “Company”) announced today that its senior management team led by Stephan Jackman, the Company’s CEO, and Ken Cragun, the Company’s CFO, will be pa...

IRRAS acquires InnerSpace Neuro assets for $700K

IRRAS has paid $700,000 for InnerSpace Neuro Solutions' assets, which include a cranial access kit, parenchymal intracranial  -More- 

Caritas Neuro Solutions & Innvocept team up

Scottish mental health and neurology research company Caritas Neuro Solutions has signed a landmark partnership deal with Mumbai, India-based group Innvocept Solutions.

Alzamend Neuro™ Announces Appointment of Dr. Eric McDade to Its Scientific Advisory Board

Company Selects Innovative Researcher and Leader, Associate Director of DIAN-TU Alzamend Neuro™, Inc. (Alzamend™ or the “Company”) announced today that it had appointed Eric McDade, DO, a bo...

Drugs and Medications [0 Results]

None

PubMed Articles [378 Associated PubMed Articles listed on BioPortfolio]

"Neuro-oncology research in Nigeria: a great untapped potential".

Nigeria has the largest population in Africa and has sub-optimal access to neuro-oncology care. It has been estimated that there is approximately 1 neurosurgeon to 2.4 million people in the country, w...

Neuro-Ophthalmic Symptoms of Primary Headache Disorders: Why the Patient With Headache May Present to Neuro-Ophthalmology.

Primary headache disorders can cause many ophthalmic symptoms that lead many patients to present for neuro-ophthalmic evaluation. Neuro-ophthalmologists frequently encounter these patients in clinical...

Association of Exercise and Swimming Goggles With Modulation of Cerebro-ocular Hemodynamics and Pressures in a Model of Spaceflight-Associated Neuro-ocular Syndrome.

Astronauts on International Space Station missions demonstrate adverse neuro-ocular changes. Reversing a negative translaminar pressure gradient (TLPG) by modulating cerebral blood flow, decreasing in...

Minocycline-Induced Vasculitis Presenting as a Third Nerve Palsy.

Endovascular Stenting in a Transgender Patient With Idiopathic Intracranial Hypertension.

Clinical Trials [340 Associated Clinical Trials listed on BioPortfolio]

Neuro 1 vs. Neuro 2 Sound Processors

This study evaluates the benefit of Neuro 1 sound processor upgrade in speech perfomance in adults. Half of participants will be tested with Neuro 1 first and Neuro 2, while the other half...

Vielight Neuro RX Gamma - Feasibility Pilot

This study tests the effects of the Neuro RX Gamma on the cognitive and behavioral functioning of subjects with moderate-to-severe Alzheimer's Disease. The Neuro RX Gamma uses non-invasive...

Efficacy of NEURO+ Attention Training For the Treatment of ADHD

This study evaluates the efficacy of the Neuro+ Attention Training System (Neuro+) in the treatment of attention-deficit/hyperactivity disorder (ADHD). Half of participants will receive th...

Neuro RX Gamma - Pivotal Phase

The active Neuro RX Gamma device uses non-invasive near-infrared energy delivered to the brain with the intention to improve cognitive functioning and quality of life in patients with mode...

Comparison Between Neuro 1 and Neuro 2 Cochlear Implant Speech Processors

The present study aims to evaluate patient satisfaction and audiological performance with their current cochlear implant speech processor, the Neuro 1, and to compare it with the satisfact...

Companies [59 Associated Companies listed on BioPortfolio]

Alzamend Neuro, Inc.

Alzamend Neuro™, Inc. is a Delaware corporation with its corporate headquarters in the State of Florida. The mission of Alzamend Neuro™ is to support the full product development life cycle...

Alzamend Neuro

Neuro Brands, LLC

Neuro is a groundbreaking brand of healthy supplement drinks designed to sustain and enhance active lives. Made with natural ingredients and packaged with recycled materials, Neuro is formulated by nu...

Ascendant Neuro

For the past 15 years, Ascendant Neuro has successfully conducted minimally invasive pain treatment techniques through the innovative use of neurostimulators. Ascendant Neuro's trained physicians, wh...

Neuro-Hitech

Neuro-Hitech is focused specifically on the development and commercialization of next-generation therapies against proven targets for neurodegenerative diseases. The company’s signature offering, Hu...

More Information about "Alzamend Neuro, Inc." on BioPortfolio

We have published hundreds of Alzamend Neuro, Inc. news stories on BioPortfolio along with dozens of Alzamend Neuro, Inc. Clinical Trials and PubMed Articles about Alzamend Neuro, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alzamend Neuro, Inc. Companies in our database. You can also find out about relevant Alzamend Neuro, Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...


Corporate Database Quicklinks



Searches Linking to this Company Record